Pharma and Biotech
| Competitors: | Hemogenyx Pharmaceuticals |
| Executive Director: | Daniel Gooding |
| Independent Non-Executive Director: | Madeleine Kennedy |
| Non-Executive Chairman: | Julian Gilbert |
| Non-Executive Dir: |
| Address: | C/O Arch Law Limited, Huckletree Bishopsgate, 8 Bishopsgate, London, United Kingdom, EC2N 4BQ |
| Phone: | +44 (0)1223 627222 |
| Website: | https://nuformix.com/ |
| Sector: | Pharma and Biotech(LSE) |
| ISIN: | GB00BYW79Y38 |
| Currency | UK Pounds |
| Share Price | 0.17p |
| Change Today | -0.030p |
| % Change | -15.00 % |
| 52 Week High | 0.49p |
| 52 Week Low | 0.074p |
| Volume | 32,171,559 |
| Shares Issued | 2,609.75m |
| Market Cap | £4.44m |
| RiskGrade | 322 |
| Value |
|
|---|
| Price Trend |
|
|---|
| Income | ![]() |
|---|
| Growth | ![]() |
|---|
| No dividends found |
| Time | Volume / Share Price |
| 16:25 | 206,243 @ 0.16p |
| 16:09 | 250,000 @ 0.16p |
| 15:48 | 284,136 @ 0.17p |
| 15:34 | 96,086 @ 0.17p |
| 15:00 | 248,471 @ 0.18p |
You are here: research